Atlas Trials

A Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy Participants

Clinical trial NCT06506175 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06506175
Sponsor
Fujian Shengdi Pharmaceutical Co., Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Weight ManagementType 2 Diabetes
Start date
2026-07-01
Primary completion
2026-09-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.